EDWARDS LIFESCIENCES CORP (EW)
US28176E1082 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.14B | 769.00M | 862.80M | 1.18B | 1.18B | |||
| Marketable Securities | 500.50M | 446.30M | 604.00M | 219.40M | 337.80M | |||
| Receivables | 836.90M | 699.10M | 664.90M | 602.80M | 599.10M | |||
| Inventories | 1.17B | 875.50M | 726.70M | 802.30M | 640.90M | |||
| Other Current Assets | 386.10M | 305.90M | 322.30M | 283.30M | 227.10M | |||
| Total Current Assets | 4.04B | 3.10B | 3.18B | 3.09B | 2.98B | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.84B | 1.73B | 1.64B | 1.49B | 1.14B | |||
| Investments And Advances | 583.90M | 1.24B | 1.83B | 801.60M | 585.50M | |||
| Goodwill | 1.25B | 1.16B | 1.17B | 1.17B | 1.17B | |||
| Intangibles | 428.40M | 285.20M | 323.60M | 331.40M | 336.50M | |||
| Other Non-Current Assets | 1.22B | 783.10M | 357.50M | 350.50M | 274.00M | |||
| Total Non-Current Assets | 5.33B | 5.20B | 5.32B | 4.15B | 3.50B | |||
| TOTAL ASSETS | 9.36B | 8.29B | 8.50B | 7.24B | 6.49B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Accrued Expenses | 819.70M | 667.80M | 714.20M | 578.70M | 642.70M | |||
| Accounts Payable | 1.37B | 201.90M | 204.50M | 196.50M | 180.40M | |||
| Other Current Liabilities | 174.30M | 152.70M | 113.60M | 118.70M | 79.30M | |||
| Total Current Liabilities | 1.20B | 1.02B | 1.03B | 893.90M | 902.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 597.00M | 596.30M | 595.70M | 595.00M | 594.40M | |||
| Deferred Taxes/Income | N/A | 267.50M | 259.00M | 214.40M | 171.70M | |||
| Other Non-Current Liabilities | 851.40M | 867.10M | 1.04B | 959.50M | 671.30M | |||
| Total Non-Current Liabilities | 1.52B | 1.46B | 1.63B | 1.77B | 1.44B | |||
| TOTAL LIABILITIES | 2.71B | 2.49B | 2.67B | 2.66B | 2.34B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 8.99B | 7.59B | 6.07B | 4.57B | 3.74B | |||
| Additional Paid In Capital | 2.27B | 1.97B | 1.70B | 1.44B | 1.62B | |||
| Minority Interest | 72.40M | N/A | N/A | N/A | N/A | |||
| Common Shares | 650.50M | 646.30M | 642.00M | 636.40M | 218.10M | |||
| Treasury Stock | -5.02B | -4.14B | -2.42B | -1.90B | -1.28B | |||
| Other Shareholders' Equity | -218.00M | -189.30M | -150.80M | -169.70M | -157.70M | |||
| Shares Outstanding | 601.10M | 608.30M | 624.10M | 624.30M | 627.30M | |||
| Tangible Book Value per Share | 8.27 | 7.16 | 6.96 | 4.92 | 4.21 | |||
| Total Shareholders' Equity | 6.65B | 5.81B | 5.84B | 4.57B | 4.15B | |||
| TOTAL LIABILITIES AND EQUITY | 9.36B | 8.29B | 8.50B | 7.24B | 6.49B | |||
| Statistics | ||||||||
| Debt/Equity | 0.09 | 0.10 | 0.10 | 0.13 | 0.14 | |||
| Current Ratio | 3.38 | 3.03 | 3.08 | 3.46 | 3.31 | |||
| Return On Assets (ROA) | 14.98% | 18.35% | 17.68% | 11.38% | 16.14% | |||
| Return On Equity (ROE) | 21.09% | 26.21% | 25.76% | 18.00% | 25.24% | |||
| Return On Invested Capital (ROIC) | 18.66% | 21.80% | 19.89% | 17.84% | 19.38% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 23.36% | 26.17% | 24.75% | 22.90% | 26.61% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 31.48% | 34.41% | 32.93% | 32.93% | 42.22% | |||
All data in USD